Platform Trials - An Adaptive Design:
Construct, Advantages and Challenges
Presented by the ISCTM Adaptive Design Working Group
Co-chairs: Ron Marcus, MD, Presenter; Judy Kando, PharmD, Moderator
with Kyle Wathen, PhD, Guest Presenter
A Platform Trial is defined by the broad goal of finding the best treatment for a disease by simultaneously investigating multiple treatments, using specialized statistical tools for allocating patients and analyzing results. The focus is on the disease rather than any particular experimental therapy. A platform trial is often intended to continue beyond the evaluation of the initial treatments and to investigate treatment combinations, to quantify differences in treatment effects in subgroups, and to treat patients as effectively as possible within the trial.
What You'll Learn:
The key issues and pragmatic challenges in designing and implementing a Platform Trial, how to proactively and reactively resolve issues, and regulatory expectations.
||Welcome and introductions
||Presentation 1 - Kyle Wathen
||Presentation 2 - Ron Marcus
||Thank You/Webinar Adjourns
Group Registration Request: Please contact the Secretariat.
Please allow 1 business day for membership processing before registering.